TNFRSF11B is associated with advanced lymph node metastasis and poorer survival outcomes in colon cancer patients, potentially by inhibiting memory-activated CD4+ T cell infiltration (Zhang et al., 2021). Here, CD4 is linked to malignant colon neoplasm.